{
  "subsection_title": "Preamble",
  "parent_section": "B",
  "page_ref": "B13",
  "pages_processed": "337-342",
  "chunks_processed": 1,
  "table_structures_detected": {
    "multi_column": false,
    "has_h_p_columns": false,
    "has_asst_surg_anae": false,
    "has_time_requirements": false,
    "has_fee_amounts": true,
    "table_sections": []
  },
  "fee_codes": [
    {
      "code": "J700",
      "description": "Solitary pulmonary nodule",
      "fee": 255.2,
      "h_fee": null,
      "p_fee": null,
      "t_fee": null,
      "asst_fee": null,
      "surg_fee": null,
      "anae_fee": null,
      "units": null,
      "conditions": "for which a diagnosis could not be established by a needle biopsy due to unsuccessful attempted needle biopsy, the SPN is inaccessible to needle biopsy, or the existence of a contra-indication to the use of needle biopsy."
    },
    {
      "code": "J701",
      "description": "Thyroid cancer",
      "fee": 255.2,
      "h_fee": null,
      "p_fee": null,
      "t_fee": null,
      "asst_fee": null,
      "surg_fee": null,
      "anae_fee": null,
      "units": null,
      "conditions": "for which standard imaging studies, including I-131 scan and/or neck ultrasound, are negative or equivocal, and recurrent or persistent disease is suspected on the basis of an elevated and/or rising thyroglobulin level(s)."
    },
    {
      "code": "J702",
      "description": "Germ cell tumour",
      "fee": 255.2,
      "h_fee": null,
      "p_fee": null,
      "t_fee": null,
      "asst_fee": null,
      "surg_fee": null,
      "anae_fee": null,
      "units": null,
      "conditions": "for which recurrent or persistent disease is suspected on the basis of elevated tumour marker(s) (beta human chorionic gonadotrophin (HCG) and/or alpha fetoprotein) in the presence of negative or equivocal standard imaging studies, or the presence of a residual mass after primary treatment for seminoma when curative surgical resection is being considered."
    },
    {
      "code": "J703",
      "description": "Colorectal cancer",
      "fee": 255.2,
      "h_fee": null,
      "p_fee": null,
      "t_fee": null,
      "asst_fee": null,
      "surg_fee": null,
      "anae_fee": null,
      "units": null,
      "conditions": "for which standard imaging studies are negative or equivocal and recurrent disease after surgical resection is suspected on the basis of an elevated and/or rising carcinoembryonic antigen (CEA) level(s)."
    },
    {
      "code": "J704",
      "description": "Lymphoma for the evaluation of a residual mass(es)",
      "fee": 255.2,
      "h_fee": null,
      "p_fee": null,
      "t_fee": null,
      "asst_fee": null,
      "surg_fee": null,
      "anae_fee": null,
      "units": null,
      "conditions": "following chemotherapy in a patient with Hodgkin\u2019s or Non-Hodgkin\u2019s lymphoma when further potentially curative therapy (such as radiation or stem cell transplantation) is being considered."
    },
    {
      "code": "J705",
      "description": "Lymphoma for the assessment of response to treatment",
      "fee": 255.2,
      "h_fee": null,
      "p_fee": null,
      "t_fee": null,
      "asst_fee": null,
      "surg_fee": null,
      "anae_fee": null,
      "units": null,
      "conditions": "in early stage Hodgkin\u2019s lymphoma following 2 or 3 cycles of chemotherapy when chemotherapy is being considered as the definitive single modality therapy."
    },
    {
      "code": "J706",
      "description": "Non-small cell lung cancer",
      "fee": 255.2,
      "h_fee": null,
      "p_fee": null,
      "t_fee": null,
      "asst_fee": null,
      "surg_fee": null,
      "anae_fee": null,
      "units": null,
      "conditions": "for which curative surgical resection is being considered based on negative standard imaging tests, or for clinical stage III NSCLC which is being considered for potentially curative combined modality therapy with radical radiotherapy and chemotherapy."
    },
    {
      "code": "J709",
      "description": "Limited disease small cell lung cancer",
      "fee": 255.2,
      "h_fee": null,
      "p_fee": null,
      "t_fee": null,
      "asst_fee": null,
      "surg_fee": null,
      "anae_fee": null,
      "units": null,
      "conditions": "for evaluation and staging where combined modality therapy with chemotherapy and radiotherapy is being considered."
    },
    {
      "code": "J710",
      "description": "Esophageal carcinoma",
      "fee": 255.2,
      "h_fee": null,
      "p_fee": null,
      "t_fee": null,
      "asst_fee": null,
      "surg_fee": null,
      "anae_fee": null,
      "units": null,
      "conditions": "baseline staging assessment of those patients diagnosed with esophageal cancer being considered for curative therapy, or repeat PET/CT scan on completion of pre-operative/neoadjuvant therapy, prior to surgery."
    },
    {
      "code": "J711",
      "description": "Metastatic squamous cell carcinoma \u2013 evaluation of neck nodes",
      "fee": 255.2,
      "h_fee": null,
      "p_fee": null,
      "t_fee": null,
      "asst_fee": null,
      "surg_fee": null,
      "anae_fee": null,
      "units": null,
      "conditions": "only insured when the primary disease site is unknown after radiologic and clinical investigation."
    },
    {
      "code": "J712",
      "description": "Liver metastasis from colorectal cancer",
      "fee": 255.2,
      "h_fee": null,
      "p_fee": null,
      "t_fee": null,
      "asst_fee": null,
      "surg_fee": null,
      "anae_fee": null,
      "units": null,
      "conditions": "prior to surgery for resection of metastatic lesions from colorectal cancer only when the surgical procedure on the liver is high risk, or the patient is considered at high risk for surgery."
    },
    {
      "code": "J713",
      "description": "Staging of nasopharyngeal carcinoma",
      "fee": 255.2,
      "h_fee": null,
      "p_fee": null,
      "t_fee": null,
      "asst_fee": null,
      "surg_fee": null,
      "anae_fee": null,
      "units": null,
      "conditions": null
    },
    {
      "code": "J707",
      "description": "cardiac PET",
      "fee": 237.5,
      "h_fee": null,
      "p_fee": null,
      "t_fee": null,
      "asst_fee": null,
      "surg_fee": null,
      "anae_fee": null,
      "units": null,
      "conditions": "for myocardial viability assessment in a patient that has moderate to severe ischemic left ventricular dysfunction (left ejection less than or equal to 40%) despite maximal medical therapy, and is a suitable candidate for a cardiac revascularization procedure or cardiac transplantation."
    }
  ],
  "referenced_codes": [
    {
      "code": "J708",
      "context": "Payment rules",
      "description": "cardiac PET with quantitative analysis, to J707... add 0%",
      "source_subsection": "Preamble",
      "source_page": "B13"
    },
    {
      "code": "J700",
      "context": "Payment rules",
      "description": "Only one of J700, J701, J702, J703, J704, J705, J706, J707, J709 or J710 is eligible for payment per patient per day.",
      "source_subsection": "Preamble",
      "source_page": "B13"
    }
  ],
  "rules": [],
  "notes": []
}